{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:42:28Z","timestamp":1793396548582,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070140"],"award-info":[{"award-number":["82070140"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["LH2021H023"],"award-info":[{"award-number":["LH2021H023"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Marshal Initiative Funding","award":["HMUMIF-22005"],"award-info":[{"award-number":["HMUMIF-22005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10528-025-11074-7","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T06:03:12Z","timestamp":1741154592000},"page":"1032-1050","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pan-Cancer Analysis of ANO6 and Experimental Validation in Metastatic Melanoma"],"prefix":"10.1007","volume":"64","author":[{"given":"Yao","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meishan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"issue":"4","key":"11074_CR1","first-page":"1103","volume":"10","author":"A Alqathama","year":"2020","unstructured":"Alqathama A (2020) BRAF in malignant melanoma progression and metastasis: potentials and challenges. Am J Cancer Res 10(4):1103\u20131114","journal-title":"Am J Cancer Res"},{"key":"11074_CR2","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1080\/14712598.2017.1378640","volume":"12","author":"T Amaral","year":"2017","unstructured":"Amaral T, Meraz-Torres F, Garbe C (2017) Immunotherapy in managing metastatic melanoma: which treatment when? Expert Opin Biol Ther 12:1523\u20131538","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"11074_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/pcmr.12172","volume":"27","author":"RR Braeuer","year":"2014","unstructured":"Braeuer RR, Watson IR, Wu CJ, Mobley AK, Kamiya T, Shoshan E, Bar-Eli M (2014) Why is melanoma so metastatic? Pigment Cell Melanoma Res 27(1):19\u201336","journal-title":"Pigment Cell Melanoma Res"},{"issue":"20","key":"11074_CR4","doi-asserted-by":"publisher","first-page":"9214","DOI":"10.7150\/thno.45125","volume":"10","author":"W Chang","year":"2020","unstructured":"Chang W, Fa H, Xiao D, Wang J (2020) Targeting phosphatidylserine for cancer therapy: prospects and challenges. Theranostics 10(20):9214\u20139229","journal-title":"Theranostics"},{"key":"11074_CR5","doi-asserted-by":"publisher","first-page":"1121285","DOI":"10.3389\/fimmu.2023.1121285","volume":"14","author":"Z Guo","year":"2023","unstructured":"Guo Z, Zhang R, Yang AG, Zheng G (2023) Diversity of immune checkpoints in cancer immunotherapy. Front Immunol 14:1121285","journal-title":"Front Immunol"},{"issue":"7793","key":"11074_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","volume":"578","author":"ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium","year":"2020","unstructured":"ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium (2020) Pan-cancer analysis of whole genomes. Nature 578(7793):82\u201393","journal-title":"Nature"},{"issue":"12","key":"11074_CR7","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1007\/s00424-013-1315-z","volume":"465","author":"KS Jacobsen","year":"2013","unstructured":"Jacobsen KS, Zeeberg K, Sauter DR, Poulsen KA, Hoffmann EK, Schwab A (2013) The role of TMEM16A (ANO1) and TMEM16F (ANO6) in cell migration. Pflugers Arch 465(12):1753\u20131762","journal-title":"Pflugers Arch"},{"issue":"2","key":"11074_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ccell.2020.10.001","volume":"39","author":"DL Jardim","year":"2021","unstructured":"Jardim DL, Goodman A, de Melo GD, Kurzrock R (2021) The challenges of tumor mutational burden as an immunotherapy biomarker. Cancer Cell 39(2):154\u2013173","journal-title":"Cancer Cell"},{"issue":"2","key":"11074_CR9","first-page":"78","volume":"70","author":"RR Kudchadkar","year":"2020","unstructured":"Kudchadkar RR, Lowe MC, Khan MK, McBrien SM (2020) Metastatic melanoma. CA Cancer J Clin 70(2):78\u201385","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"11074_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00424-013-1305-1","volume":"466","author":"K Kunzelmann","year":"2014","unstructured":"Kunzelmann K, Nilius B, Owsianik G, Schreiber R, Ousingsawat J, Sirianant L, Wanitchakool P, Bevers EM, Heemskerk JW (2014) Molecular functions of anoctamin 6 (TMEM16F): a chloride channel, cation channel, or phospholipid scramblase? Pflugers Arch 466(3):407\u2013414","journal-title":"Pflugers Arch"},{"issue":"3","key":"11074_CR11","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3390\/cancers11030382","volume":"11","author":"K Kunzelmann","year":"2019","unstructured":"Kunzelmann K, Ousingsawat J, Benedetto R, Cabrita I, Schreiber R (2019) Contribution of anoctamins to cell survival and cell death. Cancers (Basel) 11(3):382","journal-title":"Cancers (Basel)"},{"key":"11074_CR12","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s00424-024-02948-7","volume":"476","author":"IM Kur","year":"2024","unstructured":"Kur IM, Weigert A (2024) Phosphatidylserine externalization as immune checkpoint in cancer. Pflugers Arch 476:1789","journal-title":"Pflugers Arch"},{"issue":"1","key":"11074_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10067-016-3469-5","volume":"36","author":"G Layh-Schmitt","year":"2017","unstructured":"Layh-Schmitt G, Lu S, Navid F, Brooks SR, Lazowick E, Davis KM, Montagna C, Gadina M, Colbert RA (2017) Generation and differentiation of induced pluripotent stem cells reveal ankylosing spondylitis risk gene expression in bone progenitors. Clin Rheumatol 36(1):143\u2013154","journal-title":"Clin Rheumatol"},{"issue":"1","key":"11074_CR14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1186\/s12864-017-3906-0","volume":"18","author":"Y Li","year":"2017","unstructured":"Li Y, Kang K, Krahn JM, Croutwater N, Lee K, Umbach DM, Li L (2017) A comprehensive genomic pan-cancer classification using. The cancer genome Atlas gene expression data. BMC Genomics 18(1):508","journal-title":"BMC Genomics"},{"issue":"10","key":"11074_CR15","first-page":"1007","volume":"37","author":"B Li","year":"2022","unstructured":"Li B, Fan Q, Zheng L, Liu P, Fang N (2022) Significance of anoctamin 6 in progression and prognostic prediction of gastric adenocarcinoma. Histol Histopathol 37(10):1007\u20131017","journal-title":"Histol Histopathol"},{"issue":"4","key":"11074_CR16","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3390\/biomedicines12040726","volume":"12","author":"Q Lin","year":"2024","unstructured":"Lin Q, Liang L, Wang Q, Wang X, You Y, Rong Y, Zhou Y, Guo X (2024) Identification of novel tumor pyroptosis-related antigens and pyroptosis subtypes for developing mRNA vaccines in pancreatic adenocarcinoma. Biomedicines 12(4):726","journal-title":"Biomedicines"},{"issue":"11","key":"11074_CR17","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP (2018) Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res 28(11):1747\u20131756","journal-title":"Genome Res"},{"issue":"11","key":"11074_CR18","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.annonc.2020.07.014","volume":"31","author":"F Mosele","year":"2020","unstructured":"Mosele F, Remon J, Mateo J, Westphalen CB, Barlesi F, Lolkema MP, Normanno N, Scarpa A, Robson M, Meric-Bernstam F, Wagle N, Stenzinger A, Bonastre J, Bayle A, Michiels S, Bi\u00e8che I, Rouleau E, Jezdic S, Douillard JY, Reis-Filho JS, Dienstmann R, Andr\u00e9 F (2020) Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO precision medicine working group. Ann Oncol 31(11):1491\u20131505","journal-title":"Ann Oncol"},{"key":"11074_CR19","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/1346-8138.17278","volume":"51","author":"V Papa","year":"2024","unstructured":"Papa V, Li Pomi F, Borgia F, Vaccaro M, Pioggia G, Gangemi S (2024) Alarmins in cutaneous malignant melanoma: an updated overview of emerging evidence on their pathogenetic diagnostic prognostic and therapeutic role. J Dermatol 51:927","journal-title":"J Dermatol"},{"issue":"23","key":"11074_CR20","doi-asserted-by":"publisher","first-page":"5984","DOI":"10.3390\/cancers13235984","volume":"13","author":"O Papp","year":"2021","unstructured":"Papp O, Doma V, Gil J, Mark\u00f3-Varga G, K\u00e1rp\u00e1ti S, T\u00edm\u00e1r J, V\u00edzkeleti L (2021) Organ specific copy number variations in visceral metastases of human melanoma. Cancers (Basel) 13(23):5984","journal-title":"Cancers (Basel)"},{"issue":"4","key":"11074_CR21","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM (2012) The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12(4):252\u2013264","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"11074_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jmb.2014.09.028","volume":"427","author":"A Picollo","year":"2015","unstructured":"Picollo A, Malvezzi M, Accardi A (2015) TMEM16 proteins: unknown structure and confusing functions. J Mol Biol 427(1):94\u2013105","journal-title":"J Mol Biol"},{"issue":"6","key":"11074_CR23","first-page":"1005","volume":"28","author":"M Rastrelli","year":"2014","unstructured":"Rastrelli M, Tropea S, Rossi CR, Alaibac M (2014) Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo 28(6):1005\u20131011","journal-title":"In Vivo"},{"key":"11074_CR24","doi-asserted-by":"publisher","first-page":"102885","DOI":"10.1016\/j.ceca.2024.102885","volume":"120","author":"R Schreiber","year":"2024","unstructured":"Schreiber R, Ousingsawat J, Kunzelmann K (2024) The anoctamins: structure and function. Cell Calcium 120:102885","journal-title":"Cell Calcium"},{"issue":"3","key":"11074_CR25","doi-asserted-by":"publisher","first-page":"111117","DOI":"10.1016\/j.celrep.2022.111117","volume":"40","author":"JR Sim","year":"2022","unstructured":"Sim JR, Shin DH, Park PG, Park SH, Bae JY, Lee Y, Kang DY, Kim YJ, Aum S, Noh SH, Hwang SJ, Cha HR, Kim CB, Ko SH, Park S, Jeon D, Cho S, Lee GE, Kim J, Moon YH, Kim JO, Nam JS, Kim CH, Moon S, Chung YW, Park MS, Ryu JH, Namkung W, Lee JM, Lee MG (2022) Amelioration of SARS-CoV-2 infection by ANO6 phospholipid scramblase inhibition. Cell Rep 40(3):111117","journal-title":"Cell Rep"},{"issue":"3","key":"11074_CR26","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"45","key":"11074_CR27","doi-asserted-by":"publisher","first-page":"e36049","DOI":"10.1097\/MD.0000000000036049","volume":"102","author":"LH Tang","year":"2023","unstructured":"Tang LH, Dai M, Wang DH (2023) ANO6 is a reliable prognostic biomarker and correlates to macrophage polarization in breast cancer. Medicine 102(45):e36049","journal-title":"Medicine"},{"issue":"4","key":"11074_CR28","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Mokrab Y, Newman AM, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CS, Cancer Genome Atlas Research Network, Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich I (2018) The immune landscape of cancer. Immunity 48(4):812-830.e14","journal-title":"Immunity"},{"issue":"10","key":"11074_CR29","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1080\/14737140.2019.1667236","volume":"19","author":"C Turnquist","year":"2019","unstructured":"Turnquist C, Watson RA, Protheroe A, Verrill C, Sivakumar S (2019) Tumor heterogeneity: does it matter? Expert Rev Anticancer Ther 19(10):857\u2013867","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"11074_CR30","doi-asserted-by":"publisher","first-page":"2031699","DOI":"10.1080\/21645515.2022.2031699","volume":"18","author":"S Wada","year":"2022","unstructured":"Wada S, Kobayashi S, Tsunoda T (2022) Future prospects for cancer immunotherapy\u2014strategies for ineffective cancers. Hum Vaccin Immunother 18(1):2031699","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"11074_CR31","first-page":"2599","volume":"16","author":"L Wang","year":"2018","unstructured":"Wang L, Zhao XY, Zhu JS, Chen NW, Fan HN, Yang W, Guo JH (2018) CCR7 regulates ANO6 to promote migration of pancreatic ductal adenocarcinoma cells via the ERK signaling pathway. Oncol Lett 16(2):2599\u20132605","journal-title":"Oncol Lett"},{"issue":"1638","key":"11074_CR32","doi-asserted-by":"publisher","first-page":"20130096","DOI":"10.1098\/rstb.2013.0096","volume":"369","author":"P Wanitchakool","year":"2014","unstructured":"Wanitchakool P, Wolf L, Koehl GE, Sirianant L, Schreiber R, Kulkarni S, Duvvuri U, Kunzelmann K (2014) Role of anoctamins in cancer and apoptosis. Philos Trans R Soc B Biol Sci 369(1638):20130096","journal-title":"Philos Trans R Soc B Biol Sci"},{"issue":"3","key":"11074_CR33","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41423-020-00600-9","volume":"18","author":"N Wu","year":"2021","unstructured":"Wu N, Song H, Veillette A (2021a) Plasma membrane lipid scrambling causing phosphatidylserine exposure negatively regulates NK cell activation. Cell Mol Immunol 18(3):686\u2013697","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"11074_CR34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41420-021-00473-5","volume":"7","author":"ZH Wu","year":"2021","unstructured":"Wu ZH, Tang Y, Yu H, Li HD (2021b) The role of ferroptosis in breast cancer patients: a comprehensive analysis. Cell Death Discov 7(1):93","journal-title":"Cell Death Discov"},{"key":"11074_CR35","doi-asserted-by":"publisher","first-page":"6721","DOI":"10.2147\/OTT.S211725","volume":"12","author":"ZB Xuan","year":"2019","unstructured":"Xuan ZB, Wang YJ, Xie J (2019) ANO6 promotes cell proliferation and invasion in glioma through regulating the ERK signaling pathway. Onco Targets Ther 12:6721\u20136731","journal-title":"Onco Targets Ther"},{"key":"11074_CR36","doi-asserted-by":"publisher","first-page":"845093","DOI":"10.3389\/fimmu.2022.845093","volume":"13","author":"Y Yao","year":"2022","unstructured":"Yao Y, Kong X, Liu R, Xu F, Liu G, Sun C (2022) Development of a novel immune-related gene prognostic index for breast cancer. Front Immunol 13:845093","journal-title":"Front Immunol"},{"key":"11074_CR37","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/infdis\/jiy489","volume":"218","author":"P Younan","year":"2018","unstructured":"Younan P, Iampietro M, Santos RI, Ramanathan P, Popov VL, Bukreyev A (2018) Role of transmembrane protein 16F in the incorporation of phosphatidylserine into budding Ebola virus virions. J Infect Dis 218:335\u2013345","journal-title":"J Infect Dis"},{"issue":"1","key":"11074_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.chom.2017.06.012","volume":"22","author":"E Zaitseva","year":"2017","unstructured":"Zaitseva E, Zaitsev E, Melikov K, Arakelyan A, Marin M, Villasmil R, Margolis LB, Melikyan GB, Chernomordik LV (2017) Fusion stage of HIV-1 entry depends on virus-induced cell surface exposure of phosphatidylserine. Cell Host Microbe 22(1):99-110.e7","journal-title":"Cell Host Microbe"},{"issue":"12","key":"11074_CR39","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1007\/s12031-022-02087-7","volume":"72","author":"J Zhang","year":"2022","unstructured":"Zhang J, Han Y, Yan D, Zhou D, Yuan X, Zhao W, Zhang D (2022) Identification of key genes associated with risk and prognosis of neuroblastoma. J Mol Neurosci 72(12):2398\u20132412","journal-title":"J Mol Neurosci"},{"issue":"3","key":"11074_CR40","doi-asserted-by":"publisher","first-page":"e92749","DOI":"10.1371\/journal.pone.0092749","volume":"9","author":"P Zhao","year":"2014","unstructured":"Zhao P, Torcaso A, Mariano A, Xu L, Mohsin S, Zhao L, Han R (2014) Anoctamin 6 regulates C2C12 myoblast proliferation. PLoS ONE 9(3):e92749","journal-title":"PLoS ONE"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-025-11074-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-025-11074-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-025-11074-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:05:26Z","timestamp":1779357926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-025-11074-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["11074"],"URL":"https:\/\/doi.org\/10.1007\/s10528-025-11074-7","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"5 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}